Clinical Trial Update: Pembrolizumab and Stereotactic Radiosurgery for Melanoma or Non-Small Cell Lung Cancer Brain Metastases [Phase 1]

View source ↗

Summary

This phase 1 study assessed pembrolizumab in combination with stereotactic radiosurgery for patients with brain metastases from melanoma or non-small cell lung …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Cutaneous Melanoma
• Melanoma
• Melanoma of Unknown Primary
• Mucosal Melanoma
• Non-small Cell Lung Cancer
• Uveal Melanoma

Drugs mentioned

• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Emory University | Conditions: Metastatic Malignant Neoplasm in the Brain, Metastatic Melanoma | Phase 1 | Status: COMPLETED | Results posted: 2026-03-09